Klotho Neurosciences Inc (NASDAQ: KLTO) is -17.53% lower on its value in year-to-date trading and has touched a low of $0.26 and a high of $13.10 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KLTO stock was last observed hovering at around $0.37 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.40, the stock is 2.15% and -9.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing 8.40% at the moment leaves the stock -77.39% off its SMA200. KLTO registered -96.33% loss for a year compared to 6-month loss of -60.00%. The firm has a 50-day simple moving average (SMA 50) of $0.44098 and a 200-day simple moving average (SMA200) of $1.769165.
The stock witnessed a -6.32% gain in the last 1 month and extending the period to 3 months gives it a 11.42%, and is 12.26% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.80% over the week and 11.19% over the month.
Klotho Neurosciences Inc (KLTO) has around 2 employees, a market worth around $8.50M and $0.00M in sales. Distance from 52-week low is 53.85% and -96.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-235.89%).
.
Klotho Neurosciences Inc (KLTO) Top Institutional Holders
The shares outstanding are 19.86M, and float is at 16.49M with Short Float at 0.28%.
Klotho Neurosciences Inc (KLTO) Insider Activity
The most recent transaction is an insider sale by CHARDAN CAPITAL MARKETS LLC, the company’s 10% Owner. SEC filings show that CHARDAN CAPITAL MARKETS LLC sold 180,000 shares of the company’s common stock on Jul 02 ’24 at a price of $2.05 per share for a total of $0.37 million. Following the sale, the insider now owns 1.28 million shares.
Klotho Neurosciences Inc disclosed in a document filed with the SEC on Jul 01 ’24 that CHARDAN CAPITAL MARKETS LLC (10% Owner) sold a total of 115,136 shares of the company’s common stock. The trade occurred on Jul 01 ’24 and was made at $2.06 per share for $0.24 million. Following the transaction, the insider now directly holds 1.46 million shares of the KLTO stock.
Still, SEC filings show that on Jun 28 ’24, CHARDAN CAPITAL MARKETS LLC (10% Owner) disposed off 47,000 shares at an average price of $2.53 for $0.12 million. The insider now directly holds 1,579,500 shares of Klotho Neurosciences Inc (KLTO).
